The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 743K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II"selective" inhibitor celecoxib.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Synthesis and biological evaluation of cyclic and branched peptide analogues as ligands for cholecystokinin type 1 receptor.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Substituted piperidine compound and use thereofBDB
Takeda Pharmaceutical
Substituted 4-phenylpiperidines, their preparation and useBDB
Columbia University
Acylguanidines for treating osteoarthritisBDB
Merck Patent
Bicyclic heterocyclic compounds as FGFR inhibitorsBDB
Astex Therapeutics